Xu Hanyuan, Song Kai, Zhang Yuelun, Lyu Chengzhen, He Kun, Chen Wangyang, Chen Wei, Wu Dong
Department of Clinical Nutrition, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Department of Gastroenterology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Therap Adv Gastroenterol. 2025 Jul 3;18:17562848251351522. doi: 10.1177/17562848251351522. eCollection 2025.
Early detection and removal of adenomas through colonoscopy significantly reduces colorectal cancer (CRC) incidence and mortality. However, there is a lack of summarized evidence evaluating the necessity of colonoscopy in patients with upper gastrointestinal (UGI) adenomas.
We aimed to assess the risk of colorectal neoplasms in individuals with UGI adenomas to provide evidence on whether patients with UGI adenomas should undergo colonoscopy examination.
Systematic review and meta-analysis.
A search of PubMed and Embase was performed up to November 30, 2024. The studies comparing the risk of colorectal neoplasms in patients with and without UGI adenomas were included. Pooled odds ratios (ORs) of colorectal adenomas were estimated using random-effects models. Trial sequential analysis (TSA) was performed to control for random errors.
A total of 15 studies with 210,508 participants were included. Our analysis revealed a significant association between UGI adenomas and an increased risk of colorectal adenomas (pooled OR 2.36, 95% confidence interval (CI), 1.82-3.06). TSA confirmed the reliability of these findings. In addition, the presence of duodenal adenomas was linked to an increased risk of advanced colorectal adenomas (pooled OR 2.95, 95% CI, 1.80-4.84) and CRC (pooled OR 2.15, 95% CI, 1.51-3.06). Sensitivity analyses supported the robustness of these associations. Subgroup analysis suggested that patients with either gastric or duodenal adenomas had a higher risk of colorectal adenomas.
This is the first meta-analysis suggesting that patients with UGI adenomas are at increased risk of colorectal adenomas and CRC. These findings highlight the need for colonoscopy in this patient population and supplement colonoscopy screening guidelines. This meta-analysis protocol was registered on PROSPERO (CRD42024623610).
通过结肠镜检查早期发现并切除腺瘤可显著降低结直肠癌(CRC)的发病率和死亡率。然而,目前缺乏评估上消化道(UGI)腺瘤患者进行结肠镜检查必要性的汇总证据。
我们旨在评估UGI腺瘤患者发生结直肠肿瘤的风险,为UGI腺瘤患者是否应接受结肠镜检查提供依据。
系统评价和荟萃分析。
截至2024年11月30日,检索了PubMed和Embase。纳入比较有和无UGI腺瘤患者结直肠肿瘤风险的研究。使用随机效应模型估计结直肠腺瘤的合并比值比(OR)。进行试验序贯分析(TSA)以控制随机误差。
共纳入15项研究,涉及210,508名参与者。我们的分析显示,UGI腺瘤与结直肠腺瘤风险增加之间存在显著关联(合并OR 2.36,95%置信区间(CI),1.82 - 3.06)。TSA证实了这些发现的可靠性。此外,十二指肠腺瘤的存在与晚期结直肠腺瘤风险增加(合并OR 2.95,95% CI,1.80 - 4.84)和CRC风险增加(合并OR 2.15,95% CI,1.51 - 3.06)相关。敏感性分析支持这些关联的稳健性。亚组分析表明,胃或十二指肠腺瘤患者发生结直肠腺瘤的风险更高。
这是第一项荟萃分析,表明UGI腺瘤患者发生结直肠腺瘤和CRC的风险增加。这些发现凸显了该患者群体进行结肠镜检查的必要性,并补充了结肠镜筛查指南。本荟萃分析方案已在PROSPERO上注册(CRD42024623610)。